Menu
Back To Search

Tara K. Giunta

Partner, Litigation Department
T 1(202) 551-1791
F 1(202) 551-0191

Tara K. Giunta is a partner in the Litigation practice of Paul Hastings and is based in the firm’s Washington, D.C. office. Ms. Giunta is also Vice Chair of our Investigations and White Collar Defense practice and Co-Chair of our Life Sciences industry practice. Ms. Giunta has extensive experience in advising companies in sensitive industries, including life sciences/healthcare, technology, telecommunications, defense, manufacturing, and more, in:

  • Conducting due diligence on potential targets for acquisition, merger, partnering or other strategic alliance to identify and quantify risks  
  • Structuring commercial arrangements and international projects in order to protect against compliance risks and to accommodate local legal, regulatory and licensing requirements
  • Conducting internal audits and investigations internal in anti-corruption and antibribery allegations, including representing clients before US enforcement authorities
  • Conducting risk assessments for global enterprises and, based on the results, developing comprehensive compliance programs including tailoring compliance functions in highly regulated and politically exposed sectors and in widely dispersed enterprises
  • Testing and monitoring implementation of and adherence to corporate compliance policies and procedures
  • Advising clients and developing and providing training programs on compliance, particularly with regard to regulatory, anti-corruption and national security
  • Advising clients and their officers and directors on compliance in a broad range of areas, including regulatory and licensing, foreign corrupt practices act, technology transfer, data protection and national security

Experience

  • Represented a Fortune 50 healthcare company, with pharmaceutical, medical device and consumer healthcare product lines, as compliance counsel in conjunction with its global anti-corruption compliance program, which included a comprehensive and detailed risk assessment of the company’s global operations, development of detailed enhancements to its compliance program tailored to its unique risks, interviewing the executive and management personnel responsible for oversight of global operations and compliance functions, and identifying areas of improvement.
  • On behalf of a mid-sized medical device company, conducted a risk assessment and identified compliance enhancements to its initial compliance program and further enhancements to the company’s control environment. 
  • Conducted a risk assessment on behalf of a large-cap Japanese pharmaceutical company of its global operations and proposed enhancements to its compliance program, including a comprehensive review of existing global and regional policies and procedures and local standard operating procedures, interviewing the executive and management personnel responsible for oversight of global operations and compliance functions, and identifying areas of improvement and included briefing the Board of Directors and conducting anti-bribery/anti-corruption training of the C-Suite and Board.
  • We advised a large-cap Japanese pharmaceutical company on its compliance program, including detailed controls around its promotion and marketing activities, conducted directly as well as through its distributors.
  • On behalf of Fortune 50 pharmaceutical company, conduct post-acquisition risk assessment and due diligence of target in certain high risk country, identify issues for further review, and identify and recommend remediation and integration strategies.

Accolades and Recognitions

  • Recognized by Chambers USA every year since 2008
  • Recognized by The Legal 500 US 2010 and 2011
  • Recognized by Global Investigations Review (GIR) in its Women in Investigations list, which recognized 100 women across the globe who are “achieving great things in a competitive and notoriously tough area of law.” Related to her recognition, Ms. Giunta was individually profiled by GIR in a feature article which included extensive commentary in a Q&A style.

Speaking Engagements and Publications

Ms. Giunta lectures and publishes regularly and is often quoted in articles on anti-bribery/anti-corruption issues published by the FCPA Report, Inside Compliance and Compliance Week, among other leading publications. Among Ms. Giunta’s most recent speaking engagements and publications are:

  • Substantially quoted in article, “Serious Consequences for Former Louis Berger Executives Highlight Increasing Individual FCPA Risk”, The FCPA Report, July 27, 2016
  • Substantially quoted in article, “Travel and Entertainment Corruption Risks: Three Musts for a Strong T&E Policy and Five Ways a Company Can Customize Its Program (Part Two of Three)”, The FCPA Report, March 23, 2016.
  • Substantially quoted in article, “Travel and Entertainment Corruption Risks: Five Hallmarks of an Acceptable Hospitality Expenditure (Part One of Three)”, The FCPA Report, March 9, 2016.
  • Extensively quoted by The Glass Hammer relating to the Breaking the Glass Ceiling report: “Can Stock Exchanges lead the charge on board diversity?” January 13, 2016.
  • Speaker, Women Corporate Directors, Women on Boards Bootcamp, January 12, 2016.
  • Moderator, “Pale, Male and Stale: Women in the Boardroom and the Case for Good Governance”, ABA International Committee, October 23, 2015.
  • Speaker, Chief Legal Executive, Women in Corporate Governance Symposium, October 14, 2015.
  • Quoted in Corporate Counsel article entitled, “Some Countries Adding Women in the Boardroom May Surprise You”, October 12, 2015.
  • Quoted in The National Law Journal article entitled, “Achieving Gender Parity in the Boardroom”, October 2015.
  • Founder and Editor, Paul Hastings’ biannual report, “Breaking the Glass Ceiling: Women in the Boardroom,” Fourth Edition, Fall 2015.
  • Speaker, First Chair Awards Panel: “Implementing Effective Compliance Programs”, September 2, 2015.
  • Speaker, Women Corporate Directors, Women on Boards Bootcamp, June 4, 2015
  • Moderator, “Women in the Boardroom, A Public Forum for Thought Leadership”, Forum for Corporate Directors, February 20, 2015.
  • Co-authored with Michelle Cline an article for Ethical Boardroom Magazine, “Breaking the Mould: Stock Exchanges Address Boardroom Diversity”, January 23, 2015.
  • Quoted in Inside Compliance article, “Australia leads the way for diversity measures in the boardroom: New study reveals that major exchanges in Australia, New Zealand and Hong Kong have made the most tangible progress”, October 23, 2014.
  • Founder and Editor, Paul Hastings’ survey, “Breaking the Glass Ceiling: Women in the Boardroom, A Study of Major Global Exchanges,” Fall 2014.
  • Quoted in Compliance Week article, “Court Ruling Upholds Broad FCPA Definition of 'Foreign Official'”, May 28, 2014.
  • Substantially quoted in FCPA Report three-part series: “A Guide to Detecting and Preventing Expense-Reimbursement Fraud”, April 16, 2014, April 30, 2014 and May 14, 2014.
  • “Corruption Risks and the Hospitality Industry: Ensuring Compliance with Global Anticorruption Laws”, Paul Hastings Hospitality Newsletter, Spring 2014.
  • Co-authored with Matthew L. Gibson, “U.S. Chapter”, Global Telecommunications Law and Practice, Sweet & Maxwell, updated in June 2013.
  • “Anticorruption Concerns in the Life Sciences Sector,” May 15, 2013.
  • Speaker, “Conducting Effective Risk Assessments to Maximize Business and Budget Decisions”, IQPC Governance, Risk and Compliance Exchange, February 27, 2013.
  • Co-authored with Palmina M. Fava and Owen Keough, “Guidance on the U.S. Foreign Corrupt Practices Act from the Department of Justice and the Securities and Exchange Commission: The Key, as with the U.K. Bribery Act and the OECD Anti-Bribery Convention, Is a Robust Compliance Program”, Stay Current, November 2012. Also published in Ethisphere, January 11, 2013.
  • “Guidance on the U.S. Foreign Corrupt Practices Act from the Department of Justice and the Securities & Exchange Commission: The Key, as with the U.K. Bribery Act and the OECD Anti-Bribery Convention, Is a Robust Compliance Program”, Stay Current, November 20, 2012.
  • “Extraterritorial Effect of the Anti-Corruption Law of the People’s Republic of China”, Stay Current, April 27, 2011.
  • “Johnson & Johnson Reaches Settlement of Charges with US and UK Enforcement Agencies”, Stay Current, April 12, 2011.

Professional and Community Involvement

  • Member of the International Practice Committee of the Federal Communications Bar Association (FCBA), American Bar Association, District of Columbia Bar Association, and the Women’s Bar Association.  
  • She is admitted to practice in the District of Columbia.

Education

  • Catholic University of America Columbus School of Law, J.D., 1986
  • Tufts University, B.A., 1980 (cum laude)